Saeed Rafii
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- CAR-T cell therapy research
- Cancer Research top 10%
Papers in
- Oncology 19
- PARP inhibition in cancer therapy 6
- Global Cancer Incidence and Screening 4
- CAR-T cell therapy research 2
-
- Ovarian cancer diagnosis and treatment 3
- Co-authors
- Zev A. Wainberg (2 shared papers)John A. Blake-Haskins (1 shared paper)Winston W. Tan (1 shared paper)Christophe Massard (1 shared paper)Marlon Cezar Rebelatto (1 shared paper)Xiaoping Jin (1 shared paper)Peter H. O’Donnell (1 shared paper)Tyler Jay Curiel (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Human Molecular Genetics (3 papers)Frontiers in Oncology (2 papers)Breast Cancer Research (2 papers)Cancers (2 papers)
- Partner nations
- United KingdomUnited Arab EmiratesUnited States
In The Last Decade
Saeed Rafii
26 papers receiving 1.6k citations
Saeed Rafii's Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 931
- Cancer Research 182
- Obstetrics and Gynecology 90
- Immunology 233
- Reproductive Medicine 77
Countries citing papers authored by Saeed Rafii
This map shows the geographic impact of Saeed Rafii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saeed Rafii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saeed Rafii more than expected).
Fields of papers citing papers by Saeed Rafii
This network shows the impact of papers produced by Saeed Rafii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saeed Rafii. The network helps show where Saeed Rafii may publish in the future.
Co-authors
The 25 scholars most cited alongside Saeed Rafii, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer Hit paper breakdown → | 2016 | 727 |
| 2 | 2017 | 341 | |
| 3 | 2017 | 117 | |
| 4 | 2002 | 104 | |
| 5 | 2009 | 57 | |
| 6 | 2019 | 57 | |
| 7 | 2006 | 36 | |
| 8 | 2022 | 34 | |
| 9 | 2015 | 32 | |
| 10 | 2015 | 32 | |
| 11 | 2017 | 25 | |
| 12 | 1990 | 24 | |
| 13 | 2023 | 22 | |
| 14 | 2022 | 17 | |
| 15 | 2025 | 15 | |
| 16 | 2003 | 13 | |
| 17 | 2017 | 10 | |
| 18 | 2025 | 4 | |
| 19 | Driving to contract management in health care institutes of developing countries. | 2012 | 2 |
| 20 | 2016 | 2 |
About Saeed Rafii
Saeed Rafii is a scholar working on Oncology, Reproductive Medicine, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 1.7k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (6 papers), Global Cancer Incidence and Screening (4 papers), DNA Repair Mechanisms (4 papers), Ovarian cancer diagnosis and treatment (3 papers), BRCA gene mutations in cancer (3 papers), CAR-T cell therapy research (2 papers), Cell death mechanisms and regulation (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Oncology (931 citations), Cancer Research (182 citations), Obstetrics and Gynecology (90 citations), Immunology (233 citations) and Reproductive Medicine (77 citations). Saeed Rafii has collaborated with scholars based in United Kingdom, United Arab Emirates and United States. Frequent co-authors include Zev A. Wainberg, John A. Blake-Haskins, Winston W. Tan, Christophe Massard, Marlon Cezar Rebelatto, Xiaoping Jin, Peter H. O’Donnell, Tyler Jay Curiel, Omid Hamid and John F. Kurland. Their work appears in journals such as Annals of Oncology, Human Molecular Genetics, Frontiers in Oncology, Breast Cancer Research and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.